Boundless Bio, Inc. (BOLD) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist ORBIMED ADVISORS LLC mit 3,638,000 Aktien. Weitere bedeutende Anteilseigner sind Hornby Zachary und Doebele Robert.
In den letzten 12 Monaten haben Insider 11 Transaktionen in BOLD Aktien getätigt — 11 Käufe (im Wert von $1.9M) und 0 Verkäufe (im Wert von RSU Award). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
BOLD Insider-Beteiligungen
Größter Aktionär
ORBIMED ADVISORS LLC
3,638,000 Aktien
Käufe (12 Monate)
11
$1.9M Wert
Verkäufe (12 Monate)
0
$0.00 Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Orbimed Advisors Llc |
10 Percent Owner |
3,638,000 |
2018-03-12 |
|
| 2 |
Hornby Zachary |
President & CEO |
600,000 |
2026-01-26 |
|
| 3 |
Doebele Robert |
Chief Medical Officer |
230,000 |
2026-01-26 |
|
| 4 |
Hassig Christian |
Chief Scientific Officer |
230,000 |
2026-01-26 |
|
| 5 |
Oien Jessica |
See Remarks |
220,000 |
2026-01-26 |
|
| 6 |
Hinkle David A |
See Remarks |
140,000 |
2026-01-26 |
|
| 7 |
Patterson Matthew R |
Chief Executive Officer |
98,920 |
2020-01-10 |
|
| 8 |
5am Partners Iii, Llc |
Other: Former 10% Owner |
64,431 |
2017-04-26 |
|
| 9 |
Conner Edward R. |
SVP, Chief Medical Officer |
24,584 |
2019-12-16 |
|
| 10 |
Lim Jonathan E |
Director |
24,000 |
2025-06-23 |
|
| 11 |
Woiwode Thomas |
Director |
18,000 |
2016-08-25 |
|
| 12 |
Silverstein Jonathan |
10 Percent Owner |
18,000 |
2016-08-25 |
|
| 13 |
Goldberg Mark Alan |
Director |
16,200 |
2019-02-08 |
|
| 14 |
Christensen James |
Director |
16,000 |
2025-06-23 |
|
| 15 |
Lew Jennifer |
Director |
16,000 |
2025-06-23 |
|
| 16 |
Whiting Nancy |
Director |
16,000 |
2025-06-23 |
|
| 17 |
Burow Kristina |
10 Percent Owner |
16,000 |
2025-06-23 |
|
| 18 |
Brennan Christine |
Director |
16,000 |
2025-06-23 |
|
| 19 |
Soloway Thomas P |
Executive Vice President, CFO |
3,829 |
2020-01-10 |
|
| 20 |
Holles Natalie C. |
President and COO |
548 |
2019-12-16 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-01-23 |
Doebele Robert |
Chief Medical Officer |
RSU-Zuteilung |
230,000 |
$1.26 |
$289.8K |
| 2026-01-23 |
Oien Jessica |
See Remarks |
RSU-Zuteilung |
220,000 |
$1.26 |
$277.2K |
| 2026-01-23 |
Hassig Christian |
Chief Scientific Officer |
RSU-Zuteilung |
230,000 |
$1.26 |
$289.8K |
| 2026-01-23 |
Hornby Zachary |
President & CEO |
RSU-Zuteilung |
600,000 |
$1.26 |
$756K |
| 2026-01-23 |
Hinkle David A |
See Remarks |
RSU-Zuteilung |
140,000 |
$1.26 |
$176.4K |
| 2025-06-23 |
Brennan Christine |
Director |
RSU-Zuteilung |
16,000 |
$1.03 |
$16.48K |
| 2025-06-23 |
Christensen James |
Director |
RSU-Zuteilung |
16,000 |
$1.03 |
$16.48K |
| 2025-06-23 |
Whiting Nancy |
Director |
RSU-Zuteilung |
16,000 |
$1.03 |
$16.48K |
| 2025-06-23 |
Burow Kristina |
10 Percent Owner |
RSU-Zuteilung |
16,000 |
$1.03 |
$16.48K |
| 2025-06-23 |
Lew Jennifer |
Director |
RSU-Zuteilung |
16,000 |
$1.03 |
$16.48K |
| 2025-06-23 |
Lim Jonathan E |
Director |
RSU-Zuteilung |
24,000 |
$1.03 |
$24.72K |
